Intrinsiqs

Is Contineum Therapeutics, Inc. overvalued?

Contineum Therapeutics, Inc. (CTNM) — key valuation metrics and fundamentals.

No verdict
Price
$16.32
Fair value
Current P/E
Normal P/E
Market cap
$596.3M
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares CTNM's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 30 Jun 2026.